ArticleJournal of neuroimmunology2021

Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study.

Mario Habek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.